FDA Awards Fast Track Designation to Multiple Non-COVID-19
Price: $ 69.99
4.7(511)
While the world has largely been focused on the development of vaccines and therapeutics for COVID-19, the U.S. FDA has remained busy lining up potential approvals of medications for other diseases and illnesses.
Moderna's next act: more mRNA treatments after its COVID-19 vaccine
HRSA Says COVID Flexibility About Dispensing 340B Drugs in
Sellas presses ahead with fast track designation for lymphoma
FDA efficiency for approval process of COVID-19 therapeutics
Alliance Celebrates the First-Ever, FDA Traditional Approval of a
An overview of PRIME, Breakthrough Therapy & Fast Track procedures
2023 drug approvals: After a down year, FDA signs off on a bounty
The 'very, very bad look' of remdesivir, the first FDA-approved
FDA Grants Accelerated Approval to Elrexfio for Multiple Myeloma
Memo nabs fast track designation for BK polyomavirus drug
FDA Grants Breakthrough Device Designation to Anumana's ECG
Non-Small Cell Lung Cancer (NSCLC) Archives - DelveInsight
Strategies for the development and approval of COVID-19 vaccines
COVID-19: The inside story of the fastest vaccine ever developed
